Lamont urges Biden to "give us some transparency" on vaccines
"What's most important for the Biden Administration is give us some transparency," Connecticut Governor Ned Lamont said.
Watch CBS News
"What's most important for the Biden Administration is give us some transparency," Connecticut Governor Ned Lamont said.
CBS News' Manuel Bojorquez reports from Miami as the threat from new strains of coronavirus have the nation on edge.
The new coronavirus variant detected in the United Kingdom, B.1.1.7, has been identified in 30 states, according to the CDC.
A group of 10 Republican senators wrote Mr. Biden a letter Sunday requesting a meeting to discuss coronavirus relief framework, which they said has bipartisan support.
Distributing the coronavirus vaccine has proven to be a significant challenge across the country, including the vast, sparsely populated Alaskan state. Two organizations in western Alaska have been working to vaccinate Alaskans in the thick of winter. Nancy Chen introduces some of those frontline workers and the unique ways they're getting to their patients.
Many vaccination sites across the U.S. are working overtime to increase vaccinations, just as the U.K. and South Africa COVID-19 variants are becoming more prominent nationwide. Danya Bacchus has more.
The Pentagon paused a plan to vaccinate Guantanamo Bay detainees after Republican lawmakers criticized the decision.
The race to vaccinate people picks up worldwide as the scramble for vaccine supplies is becoming heated. The European Union reversed its decision Friday after they implied they would start to restrict exports of coronavirus shots to Northern Ireland. Imtiaz Tyab reports.
President Biden spent his first full week at the White House focused on getting more Americans vaccinated and his coronavirus rescue package passed by Congress. But his proposed economic relief package is getting some pushback from Republicans in Congress. Christina Ruffini has the latest.
Dr. Amesh Adalja, senior scholar at the Johns Hopkins Center for Health Security, joins "CBS This Morning: Saturday" to discuss Johnson & Johnson's new COVID-19 vaccine, as well as the state of vaccination in the U.S.
Information from 23 states that report COVID-19 vaccinations by race and ethnicity shows a stark difference in the rollout, with communities hit hardest by the virus lagging or being left behind. Adriana Diaz has the details.
The government envisions 50 "mega" vaccination sites capable of administering 6,000 shots per day, in addition to 50 "large" vaccination sites providing 3,000 shots per day, according to defense officials.
Johnson & Johnson says its single dose coronavirus vaccine protects against even the most severe cases of the infection. The company will seek emergency-use authorization as pressure mounts to get Americans vaccinated and curb the spread of dangerous new variants. Infectious disease specialist Dr. Uzma Syed joined CBSN to break down the latest.
Black and Latinos are more likely to die from the coronavirus, but people of color are significantly behind White Americans in receiving the vaccine -- despite having a higher death rate. Adriana Diaz reports.
Johnson and Johnson's single shot COVID-19 vaccine is bringing new hope in the race to vaccinate Americans. Trials showed the vaccine largely prevented moderate and severe cases. Mola Lenghi has the latest.
Pharmaceutical company Johnson and Johnson says its single-shot coronavirus vaccine has proven effective at preventing severe illness in clinical trials. This comes as a new variant of the virus, originally seen in South Africa, has surfaced in the U.S. CBS News' Mola Lenghi reports, and Dr. Annette Reboli of Cooper Medical School of Rowan University joins CBSN's Tanya Rivero to discuss the latest developments.
Johnson and Johnson has reported promising results from its single-dose coronavirus vaccine and plans to apply for emergency use authorization in early February. Meanwhile, the virus variant first identified in South Africa has now been found in the United States. CBS News' Mola Lenghi reports, and Dr. Bob Lahita spoke with CBSN's Anne-Marie Green and Vladimir Duthiers about the highly contagious new strain and the work drugmakers are doing to fight variants that continue to appear.
Blanket approval will be welcome news amid vaccine shortages across the bloc of 450 million people and worries about limited trial data for older adults.
A dangerous new coronavirus strain has turned up in the U.S., infecting two patients in different parts of South Carolina. The discovery comes as another highly infectious variant takes hold. CBS News' Debra Alfarone joined "CBSN AM" with the latest and what's happening with President Biden's COVID-19 aid package.
Johnson & Johnson announced that their new single-dose vaccine showed 85% protection against severe cases of COVID-19. Some advantages of the new vaccine: it's a single dose and can be stored in a regular refrigerator. Dr.Tara Narula details how this new vaccine works.
CDC Director Dr. Rochelle Walensky joined "CBS This Morning" to discuss the rollout and production of COVID-19 vaccines in the United States.
A highly transmissible strain of the coronavirus, first detected in South Africa, has infected at least two people in South Carolina. The state's governor is telling residents not to panic. Mola Lenghi reports.
Norah O'Donnell interviews President Biden's chief of staff Ron Klain about increasing the vaccine supply, reopening schools and the coronavirus relief bill.
On "Facing Forward," Margaret Brennan talks with Eli Lilly CEO David Ricks about what the company is doing to keep up with treating an evolving pandemic.
After 14-year-old Emilian Sosa sent a letter asking for access to a last-ditch COVID-19 treatment for his severely ill mother, Texas Governor Greg Abbott tweeted Wednesday that the equipment had been located. Sosa's mother is expected to be transported to the new hospital shortly. Mireya Villarreal reports.